STOCK TITAN

Axcelis Technologies (ACLS) Stock News

ACLS NASDAQ

Axcelis Technologies reports developments tied to its role as a supplier of ion implantation systems and process applications for semiconductor manufacturing. Company updates commonly cover quarterly results, demand trends across memory, power, compound semiconductor and mature-node markets, and the performance of its customer support and installed-base services business.

News also includes technical participation at semiconductor industry conferences, lifecycle support for Purion-based implant platforms, sustainability targets for greenhouse gas emissions, investor-conference activity and governance changes such as finance leadership transitions. The recurring business context centers on equipment used in integrated-circuit fabrication and aftermarket services including spare parts, upgrades, maintenance and training.

Rhea-AI Summary

Axcelis Technologies (ACLS) plans to participate in the UBS Global Technology and AI Conference, with management hosting small group meetings on December 1, 2026. The conference runs November 30–December 3, 2026, at the Phoenician Hotel in Scottsdale, Arizona.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

Axcelis Technologies (Nasdaq: ACLS) reported third-quarter 2026 revenue of $237.8 million, with earnings rising from the same quarter a year earlier. GAAP net income reached $37.759 million, versus $25.986 million, and diluted earnings per share rose to $1.21 from $0.83. Gross margin declined to 41.0% from 41.6%, while operating margin eased to 11.5% from 11.7%.

Revenue compared with $213.611 million a year earlier. Operating cash flow fell to $40.221 million from $45.350 million. Axcelis cited increased bookings, sequential systems revenue growth and record quarterly CS&I revenue, while foreign exchange weighed on gross margin. For the fourth quarter ending December 31, 2026, the company expects approximately $275 million in revenue, GAAP diluted EPS of approximately $1.15 and non-GAAP EPS of approximately $1.50.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.32%
Tags
-
Rhea-AI Summary

Axcelis Technologies (ACLS) and Veeco Instruments (VECO) now expect their all-stock merger to close by the end of the first quarter of 2027.

Completion remains subject to closing conditions, including pending approval from China's State Administration for Market Regulation (SAMR). The companies continue working with SAMR to obtain clearance. With the current U.S. antitrust clearance nearing expiry, the parties plan to promptly make a new submission under the Hart-Scott-Rodino Act. Closing also requires the waiting period for that new submission to expire or be terminated early.

At closing, each Veeco common share will convert into 0.3575 Axcelis shares. The expected closing timeline is not assured.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.92%
Tags
Rhea-AI Summary

Axcelis Technologies (ACLS) appointed Jeroen Delsman as Executive Vice President and Chief Financial Officer, effective November 12, 2026.

David Ryzhik, who has served as Interim CFO during the transition, will become Senior Vice President, Corporate Development and Investor Relations, reporting directly to President and CEO Russell Low. His responsibilities will include leading integration planning and execution related to the pending merger with Veeco, as well as corporate development, investor relations and other strategic initiatives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.15%
Tags
none
-
Rhea-AI Summary

Axcelis Technologies (ACLS) will release its third-quarter 2026 financial results before the market opens on November 5, 2026.

A conference call to discuss the results will follow at 8:30 a.m. ET that day. The webcast will be accessible through the Investors page at www.axcelis.com, with replays available for 30 days following the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.23%
Tags
conferences earnings
-
Rhea-AI Summary

Axcelis Technologies (Nasdaq: ACLS) announced plans to break ground on a new semiconductor equipment manufacturing facility in Pyeongtaek, Korea. The $35 million investment will expand the company's existing Korean manufacturing operations, known as the Axcelis Asia Operations Center. The new site will manufacture ion implantation equipment used in semiconductor production.

The facility will encompass approximately 200,000 square feet of total gross floor area, with warehousing, cleanrooms and a training center. Production is scheduled to commence in the second half of 2028. Axcelis said the investment is intended to strengthen its high-volume manufacturing infrastructure and expand its capacity to serve customers worldwide. The design will incorporate a lean production environment drawing on the company's equipment manufacturing experience.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.55%
Tags
none
Rhea-AI Summary

Axcelis Technologies (ACLS) will participate in the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026) in Yokohama, Japan, from September 28 to October 2, 2026.

The company will host an exhibit at Booth #F3 and its technologists and collaborators will present multiple papers on silicon carbide ion implantation, including stacking fault suppression, contact engineering, manufacturability of 1200V superjunction pillars, and MOSFET performance sensitivity. The company highlights its Purion Power Series+™ platform for SiC power devices and cites Yole Group’s estimate that the silicon carbide device market may reach $11 billion by 2031, growing at a 20% CAGR from 2025 to 2031.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.50%
Tags
none
-
Rhea-AI Summary

Axcelis Technologies (ACLS) will be a Platinum Sponsor of the 25th International Conference on Ion Implantation and Annealing Technology (IIT 2026), held September 20-24, 2026 at the Congress Center Villach in Austria.

The company will host an exhibit at Booth #7 and its technologists and collaborators will present on topics including implant innovation, SiC MOSFET manufacturing, aluminum ion implantation performance, implant platform developments such as realtime beam shape monitoring and beam energy measurement, wafer backside particle reduction, and emerging research in advanced CMOS contact module engineering and resonator devices. Axcelis' president and CEO said the company is committed to enabling next-generation semiconductor device manufacturing with its ion implantation technologies. Additional event and registration details are available on the IIT 2026 conference website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.16%
Tags
none
-
Rhea-AI Summary

Axcelis Technologies (ACLS)/b) plans to invest $35 million to build a new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, Korea.The project expands Axcelis' global high-volume manufacturing infrastructure to better support growing semiconductor demand. The company said production at the new facility is scheduled to begin in the second half of 2028, following a groundbreaking ceremony planned for October 20, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.55%
Tags
none
Rhea-AI Summary

Axcelis Technologies (NASDAQ: ACLS) announced it will participate in two upcoming investor conferences in New York. The company plans to attend the Citi 2026 Global TMT Conference on Tuesday, September 8 at the New York Hilton Midtown and the B. Riley Securities Consumer & TMT Conference on Thursday, September 10 at the InterContinental New York Times Square. Axcelis highlights its 45-plus years of providing ion implantation solutions for the semiconductor industry and lists dedicated investor relations and media contacts for further information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.54%
Tags
conferences

FAQ

What is the current stock price of Axcelis Technologies (ACLS)?

Axcelis Technologies (ACLS) last closed at $99.22.

What is the market cap of Axcelis Technologies (ACLS)?

The market cap of Axcelis Technologies (ACLS) is approximately $3.1B.